Three-dimensional printing technology has emerged as a versatile and cost-effective alternative for the fabrication of electrochemical sensors. To enhance sensor sensitivity and biocompatibility, a diverse range of biocompatible and conductive materials can be employed in these devices. This allows these sensors to be modified to detect a wide range of analytes in various fields. 3D-printed electrochemical sensors have the potential to play a pivotal role in personalized medicine by enabling the real-time monitoring of metabolite and biomarker levels. These data can be used to personalize treatment strategies and optimize patient outcomes. The portability and low-cost nature of 3D-printed electrochemical sensors make them suitable for point-of-care (POC) diagnostics. These tests enable rapid and decentralized analyses, aiding in diagnosis and treatment decisions in resource-limited settings. Among the techniques widely reported in the literature for 3D printing, the fused deposition modeling (FDM) technique is the most commonly used for the development of electrochemical devices due to the easy accessibility of equipment and materials. Focusing on the FDM technique, this review explores the critical factors influencing the fabrication of electrochemical sensors and discusses potential applications in clinical analysis, while acknowledging the challenges that need to be overcome for its effective adoption.
This study investigated the effect of surface treatments on the electrochemical performance of 3D-printed electrodes for versatile applications. The conductive filament was obtained from a mixture of polylactic acid (PLA) and carbon black (CB) at a 7:3 ratio (PLA/CB) dispersed in acetic acid and dichloroethane (3:1) medium. The treatments used were HNO3, NaOH, DMF (immersion for 30, 30, and 15 min, respectively), and electrochemical activation (amperometry 150 s, 1.8 V). In general, the treatments allow greater exposure of the conductive material and active sites present on the sensor surface. This was confirmed using cyclic voltammetry and electrochemical impedance spectroscopy. The analyses were conducted with a 0.10 M KCl solution containing the redox pair ferricyanide/ferrocyanide 5.00 mmol L−1. Based on the results obtained, the electroactive area, kinetic constant and resistance to electron transfer were determined for each treatment. The treatment in basic medium stood out as the treatment that was most appropriate for the device used in this work. The device was also tested for its potential in the analysis of acetaminophen, demonstrating satisfactory results permitting the application of 3D-SBasic in the analysis of acetaminophen.
In this work, we described the development an electrochemical sensor based on electroreduction of graphene oxide (rGO) on a glassy carbon electrode (GCE) for simultaneous determination of l-Dopa and benserazide. For the elaboration of the GCE/rGO, the developed methodology was based on the electrochemical technique: multiple pulse amperometry (MPA). The MPA was more stable and efficient for the formation of rGO film, under optimum conditions (pH 6.00; concentration of rGO 2.00 mg mL−1; time 450 s; potentials −0.60, −0.70, −0.80, −0.90, −0.95, −1.00, −1.10, −1.20, and – 1.30 V). After the film was formed, the cyclic voltammetry was used to detect LD and BZ in real samples and optimized conditions 0.05 mol L−1 PBS (pH 5.50). The linear range for the LD is 25–425 μmol L−1 and the BZ of 5–80 μmol L−1. The limit of detection calculated was 17.10 (LD) and 2.99 (BZ) μmol L−1.